Thought Leader Liaison Director - Hematology

Sumitomo Pharma•Marlborough, MA

5d•Hybrid

About The Position

Sumitomo Pharma America, Inc. is seeking a dynamic, motivated, and experienced individual for the position of Thought Leader Liaison Director – Hematology (Enzomenib). This field-based role will focus on shaping the external thought leader ecosystem and pre-launch readiness for enzomenib, while also supporting the eventual transition to an in-market commercial role. The TLL will engage hematology thought leaders across academic centers and leading community institutions, generate insights to inform launch planning and strategy, and ensure continuity of engagement and impact through commercialization.

Requirements

Bachelor’s degree required; advanced degree in life sciences or healthcare strongly preferred
Minimum 10 years of relevant experience in the biotechnology or pharmaceutical industry
Prior Thought Leader Liaison (TLL) in Hematology strongly preferred, including experience engaging leukemia or hematologic malignancy experts
Deep understanding of the hematology landscape, including acute leukemia treatment paradigms, academic centers, and key opinion leader networks
Demonstrated success engaging KOLs and translating insights into actionable commercial strategies
Experience supporting pre-launch or launch of a hematology/oncology asset strongly preferred
Excellent communication skills with strong credibility among hematology/oncology clinical leaders.
Strong knowledge of acute leukemia and hematologic malignancy treatment landscape.
Strategic mindset with ability to translate insights into business impact.
Advanced cross-functional collaboration and leadership skills.
High standards of compliance and sound judgment.
Strong organizational awareness and ability to operate in a matrixed environment.
Must be able to exercise appropriate judgment as necessary.
Requires a high level of initiative and independence.
Excellent written and oral communication skills required.
Requires ability to use a personal computer for extended periods of time.

Responsibilities

Develop and execute a pre-launch thought leader engagement plan for enzomenib, including identification, profiling, and prioritization of key hematology/oncology experts and emerging voices.
Map the thought leader landscape, influence pathways, and treatment ecosystem to inform launch targeting, segmentation, and engagement strategy.
Build and strengthen relationships with thought leaders in acute leukemia and related hematologic malignancies, aligning engagement with development and launch milestones.
Capture and synthesize external insights on unmet need, treatment patterns, diagnostic considerations, and adoption barriers, translating findings into actionable launch strategy implications.
Partner cross-functionally to shape advisory board strategy and ensure meaningful, compliant insight generation.
Provide field perspective and external feedback to refine pre-launch narrative, messaging, and engagement approaches.
Serve as thought leader engagement lead within the cross-functional launch team, integrating insights into launch readiness plans.
Coordinate planning for key congress engagements and scientific meetings in partnership with internal stakeholders.
Educate internal teams on the evolving hematology landscape and thought leader ecosystem ahead of launch.
Ensure all engagement and insight generation activities are compliant and appropriate for a pre-launch activity.
Support transition from pre-launch to commercialization, maintaining continuity of thought leader relationships and aligning engagement with evolving brand priorities.
Drive post-launch thought leader engagement and insight generation to inform adoption, advocacy development, and ongoing lifecycle strategy.